MassDevice

Field Medical reports positive first-in-human PFA data for AFib

Field Medical announced the presentation of clinical data from the first-in-human study of its FieldForce pulsed field ...

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate the strong safety and efficacy of the ...

Field Medical, Inc.: Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF ...
Business Wire

MedLumics is Proud to Announce the Completion of the FIM Study, With Successful Remapping at 3 Months, Demonstrating the Efficacy of the AblaView® Optically Guided Pulsed ...

MADRID--(BUSINESS WIRE)--“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the ...
Vietnam Investment Review on MSN

Field Medical shares PULSE trial results

CARDIFF-BY-THE-SEA, Calif., Feb. 6, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing pulsed field ablation (PFA) solutions for complex cardiac ...